CCI dismisses complaint against Cipla, chemist body over alleged non-supply of medicines Farhat Nasim21 May 2019 9:45 AM ISTNew Delhi: In a major relief to Mumbai based Cipla Ltd and Bengal Chemist and Druggists Association (BCDA), the Competition Commission of India has...
Cipla gets no USFDA observations for Indore facility Farhat Nasim18 May 2019 9:45 AM ISTThe US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
China war on healthcare costs lure Indian drugmaker Sun Pharma: Report Medical Dialogues Bureau6 May 2019 9:15 AM ISTChina has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
NPPA fixes retail price of 20 drugs including FDCs for Blood pressure control, dual antiplatelet Meghna A Singhania4 May 2019 12:31 PM ISTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension Farhat Nasim30 April 2019 10:00 AM ISTCipla's Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc's Letairis.New Delhi: Drug major...
Cipla appoints Dr Raju Mistry as Global Chief People Officer Medical Dialogues Bureau23 April 2019 9:15 AM ISTIn her role at Cipla, Raju Mistry will oversee Human Resources, and Administration and Facilities Management. She will be a member of the Management...
Cipla acquires 30 percent stake in Brandmed for Rs 32 crore Garima18 April 2019 9:15 AM ISTThe acquisition of Brandmed is expected to complete by May 31. The transaction worth Rs 32 crore will be executed by the company's South African arm...
Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma Garima16 April 2019 9:40 AM ISTPulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
CDSCO expert committee suggests ban of yet another 324 FDCs Meghna A Singhania15 April 2019 11:49 AM ISTNew Delhi: Domestic drugmakers are likely to face a blow as 324 Fixed Dose Combination (FDCs) drugs have been recommended to be banned by an expert...
Cipla launches respiratory inhalation therapy product Niveoli in India Farhat Nasim12 April 2019 11:41 AM ISTNew Delhi: Drug major Cipla Friday announced the launch of its proprietary respiratory inhalation therapy product 'Niveoli' in India. Niveoli is used...
Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole Garima2 April 2019 9:45 AM ISTThe agreement has been signed between the company's wholly-owned subsidiary in the US, Cipla Technologies LLC with Pulmatrix Inc for investment in...
Cipla gets 8 USFDA observations for Kurkumbh plant Farhat Nasim1 April 2019 9:55 AM ISTThe inspection covered three units at the plant. Post the conclusion of the inspection, the company received 8 GMP observations. The company also...
